BEIJING (AP) — Drug manufacturer GlaxoSmithKline, under investigation in China for possible bribery of doctors, says some of its executives may have broken Chinese law.
The British company said today its president for international operations met with Chinese police officials who are investigating whether GSK employees bribed doctors and hospital administrators to prescribe its drugs.
The executive, Abbas Hussain, said in a statement, “Certain senior executives of GSK China who know our systems well appear to have acted outside of our processes and controls, which breaches Chinese law.”
The police ministry has said four employees of GSK’s China unit, including a vice president, have been detained.
The company says its finance director for China is barred from leaving the country but is not detained.